Prostate Cancer Therapeutics Global Market Key Developments, Outlook, 2017 Analysis & Forecast to 2023
ReportsWeb.com published “Prostate Cancer Therapeutics Global Market” from its database. This report Strategic recommendations in key business segments based on the market estimations. This report Supply chain trends mapping the latest technological advan
(EMAILWIRE.COM, July 26, 2017 ) Increase in prostate cancer cases in recent years and raise in development of innovative drugs are the some of the prominent factors driving the market growth. Whereas high cost and low success rate in the clinical test are hampering the market. However, increase in geriatric population and increase in R&D expenditure in this market seems to be opportunity for the market growth. In 2016, North America accounted for the highest market share owing to increase in research and development expenditure. The Asia Pacific region is expected to grow at a higher CAGR and is anticipated to account for the highest market share during forecast period because of government initiatives on creating awareness on prostate cancer.
For more information about this report: http://www.reportsweb.com/prostate-cancer-therapeutics-global-market-outlook-2017-2023
Some of the key players in the market include Tolmar Inc, Teva Pharmaceutical Industries Ltd, Takeda Pharmaceutical Co. Ltd, Sanofi-Aventis, Pfizer Inc, Johnson & Johnson, Ipsen, Ferring Pharmaceuticals, Endo Pharmaceuticals Inc (Indevus Pharmaceuticals Inc), Dendreon Corporation, Bristol-Myers Squibb, Astrazeneca Plc, Astellas Pharma Inc, Active Biotech and Abbott Laboratories.
Drugs Classes Covered:
-Chemotherapy
- Estramustine (Emcyt)
- Mitoxantrone (Novantrone)
- Jevtana
- Taxotere
-Targeted Therapy
- Xofigo
-Hormonal Therapy
- Anti-Androgens
- Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists
- Luteinizing Hormone-Releasing Hormone (LHRH) Analogs
-Immunotherapy
- Provenge
Distribution Channels Covered:
-Hospital Pharmacy
-Retail Pharmacy
-Online Sales
-Other Distribution Channels
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001888512/sample
Regions Covered:
-North America
- US
- Canada
- Mexico
-Europe
- Germany
- France
- Italy
- UK
- Spain
- Rest of Europe
-Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- Rest of Asia Pacific
-Rest of the World
- Middle East
- Brazil
- Argentina
- South Africa
- Egypt
Company Profiling
9.1 Tolmar Inc
9.2 Teva Pharmaceutical Industries Ltd
9.3 Takeda Pharmaceutical Co. Ltd
9.4 Sanofi-Aventis
9.5 Pfizer Inc
9.6 Johnson & Johnson
9.7 Ipsen
9.8 Ferring Pharmaceuticals
9.9 Endo Pharmaceuticals Inc (Indevus Pharmaceuticals Inc)
9.10 Dendreon Corporation
9.11 Bristol-Myers Squibb
9.12 Astrazeneca Plc
9.13 Astellas Pharma Inc
9.14 Active Biotech
9.15 Abbott Laboratories
Inquire before Buying at http://www.reportsweb.com/inquiry&RW0001888512/buying
For more information about this report: http://www.reportsweb.com/prostate-cancer-therapeutics-global-market-outlook-2017-2023
Some of the key players in the market include Tolmar Inc, Teva Pharmaceutical Industries Ltd, Takeda Pharmaceutical Co. Ltd, Sanofi-Aventis, Pfizer Inc, Johnson & Johnson, Ipsen, Ferring Pharmaceuticals, Endo Pharmaceuticals Inc (Indevus Pharmaceuticals Inc), Dendreon Corporation, Bristol-Myers Squibb, Astrazeneca Plc, Astellas Pharma Inc, Active Biotech and Abbott Laboratories.
Drugs Classes Covered:
-Chemotherapy
- Estramustine (Emcyt)
- Mitoxantrone (Novantrone)
- Jevtana
- Taxotere
-Targeted Therapy
- Xofigo
-Hormonal Therapy
- Anti-Androgens
- Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists
- Luteinizing Hormone-Releasing Hormone (LHRH) Analogs
-Immunotherapy
- Provenge
Distribution Channels Covered:
-Hospital Pharmacy
-Retail Pharmacy
-Online Sales
-Other Distribution Channels
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001888512/sample
Regions Covered:
-North America
- US
- Canada
- Mexico
-Europe
- Germany
- France
- Italy
- UK
- Spain
- Rest of Europe
-Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- Rest of Asia Pacific
-Rest of the World
- Middle East
- Brazil
- Argentina
- South Africa
- Egypt
Company Profiling
9.1 Tolmar Inc
9.2 Teva Pharmaceutical Industries Ltd
9.3 Takeda Pharmaceutical Co. Ltd
9.4 Sanofi-Aventis
9.5 Pfizer Inc
9.6 Johnson & Johnson
9.7 Ipsen
9.8 Ferring Pharmaceuticals
9.9 Endo Pharmaceuticals Inc (Indevus Pharmaceuticals Inc)
9.10 Dendreon Corporation
9.11 Bristol-Myers Squibb
9.12 Astrazeneca Plc
9.13 Astellas Pharma Inc
9.14 Active Biotech
9.15 Abbott Laboratories
Inquire before Buying at http://www.reportsweb.com/inquiry&RW0001888512/buying
Contact Information:
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results